WASHINGTON (dpa-AFX) - It is almost the end of the year. With the exception
of a few, many of the biotech stocks, like the following, on which investors had
bet big this year have served up only heartbreak.
It's been a downer year for...
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.